Skip to main content

Accupril News

FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets Due to Potential Presence of N-Nitroso-Quinapril Impurity

Baltimore, Maryland, December 21, 2022 – Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a...

FDA Medwatch Alert: Pfizer Voluntary Nationwide Recall of Lots of Accupril (Quinapril HCl) Due to N-Nitroso-Quinapril Content

NEW YORK, NY., April 22,2022 - Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level due to the presence of a...

FDA Medwatch Alert: Angiotensin-converting enzyme inhibitor (ACE inhibitors) drug class

[Posted 06/07/2006] The New England Journal of Medicine published an article reporting that infants whose mothers had taken an angiotensin-converting enzyme inhibitor (ACE inhibitors) drug during the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

High Blood Pressure, Hypertension, Heart Failure, Congestive Heart Failure, Left Ventricular Dysfunction

Accupril patient information at Drugs.com